I was deeply saddened to hear about the passing of Sally Ride, the first American woman in space, who lost her 17- month battle with pancreatic cancer. She had an inspiring, accomplished career and is an icon in our nation’s history.
Tragically, for those who have been touched by pancreatic cancer, 17 months is an exception. Seventy-four percent of patients die within the first year of diagnosis. Perhaps what is worse is that pancreatic cancer’s five-year survival rate of just 6 percent has not improved substantially in over 40 years since the passage of the National Cancer Act.
My own dad lived a mere nineand a-half months after his diagnosis despite his healthful lifestyle and excellent medical care. Since getting involved with volunteering for the Pancreatic Cancer Action Network, I have met countless individuals who have lost loved ones in much less time – even as short as two weeks.
We need Congress to pass the Pancreatic Cancer Research and Education Act (S. 362/H.R. 733) which would put a long-term comprehensive strategic research plan in place to develop effective treatment options and ultimately give those diagnosed with pancreatic cancer a fighting chance.
The bill is currently being debated and has strong bipartisan support in Congress. In fact, with nearly 60 Senate co-sponsors and more than 270 House co-sponsors, the bill has more bipartisan support than the overwhelming majority of bills currently under consideration.
I hope all those inspired by Sally Ride will honor her memory by joining the fight against pancreatic cancer. To learn ways that you can help, visit www.pancan.org. Together we can know, fight and end this deadly disease.
Jill Rothstein
Freehold Township